GBR-13069
Names
Preferred IUPAC name
1-{2-[Bis(4-fluorophenyl)methoxy]ethyl}-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
UNII
  • InChI=1S/C28H30F2N2O/c29-26-12-8-24(9-13-26)28(25-10-14-27(30)15-11-25)33-22-21-32-19-17-31(18-20-32)16-4-7-23-5-2-1-3-6-23/h1-15,28H,16-22H2/b7-4+
    Key: DASHZBBQOARCMQ-QPJJXVBHSA-N
  • InChI=1/C28H30F2N2O/c29-26-12-8-24(9-13-26)28(25-10-14-27(30)15-11-25)33-22-21-32-19-17-31(18-20-32)16-4-7-23-5-2-1-3-6-23/h1-15,28H,16-22H2/b7-4+
    Key: DASHZBBQOARCMQ-QPJJXVBHBX
  • C1CN(CCN1CCOC(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)C/C=C/C4=CC=CC=C4
Properties
C28H30F2N2O
Molar mass 448.558 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

GBR-13069 is a psychostimulant and selective dopamine reuptake inhibitor.[1]

See also

References

  1. ^ Vaugeois, Jean-Marie; Bonnet, Jean-Jacques; Duterte-Boucher, Dominique; Costentin, Jean (January 1993). "In vivo occupancy of the striatal dopamine uptake complex by various inhibitors does not predict their effects on locomotion". Eur. J. Pharmacol. 230 (2): 195–201. doi:10.1016/0014-2999(93)90802-o. PMID 8422901.